What's New

With a transaction signed on 2 September 2024, Mehiläinen has acquired Docrates Ltd, as a result of which Docrates Cancer...

On 27, August 2024, the Finnish Competition and Consumer Authority (FCCA) approved the merger of Mehiläinen and Docrates Cancer Center....

Breast cancer is a serious disease that requires individual care and expertise. As part of cancer treatment, the patient may...

Docrates treats metastatic colorectal cancer in a personalised way, and its treatment recommendations are based on the latest research and...

Cancer is a rapidly evolving medical specialty. Docrates publishes the latest news about cancer treatment, diagnostics and research a number...

Hannu Nurmio was aware that prostate cancer is the most common cancer in older men. However, after the diagnosis was confirmed,...

A temporary technical problem occurred in the data network connections of Docrates Cancer Center. We apologise for any delays caused...

Early detection of colorectal cancer is crucial for successful treatment. If diagnosed early, up to 90% of cancers can be...

Docrates Cancer Center is the first service provider in the Nordic region to launch a new experimental alpha radiation treatment...

The treatment path of colorectal cancer is always individual and planned with you by experienced oncologists at Docrates. Docrates also...

Please be prepared to present an identity document when you register at the reception.

In 2023, Docrates Cancer Center promoted its strategy by investing in larger facilities, developing services related to the early detection...